NDC 53746-254 – Ranitidine
Ranitidine Hydrochloride 300 mg/1 · Tablet · Oral
Product NDC53746-254
Product details
- Brand name
- Ranitidine
- Generic name
- Ranitidine
- Labeler
- Amneal Pharmaceuticals of New York LLC
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA077824
- Marketed since
- December 16, 2009
- Listing expires
- December 31, 2027
- Pharmacologic class
- Histamine-2 Receptor Antagonist
Active ingredients
- Ranitidine Hydrochloride 300 mg/1
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 53746-254-01 | 100 TABLET in 1 BOTTLE (53746-254-01) | Dec 16, 2009 |
| 53746-254-02 | 250 TABLET in 1 BOTTLE (53746-254-02) | Dec 16, 2009 |
| 53746-254-30 | 30 TABLET in 1 BOTTLE (53746-254-30) | Dec 16, 2009 |
Recalls mentioning this NDC
- D-0616-2020 Dec 18, 2019 · Class II
CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API - D-0615-2020 Dec 18, 2019 · Class II
CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API
Other Ranitidine products
- 53746-253 Ranitidine Hydrochloride 150 mg/1 · Tablet · Amneal Pharmaceuticals of New York LLC
- 55111-131 Ranitidine Hydrochloride 75 mg/1 · Tablet · Dr. Reddy's Laboratories Limited
- 62207-773 Ranitidine Hydrochloride 150 mg/1 · Tablet · Granules India Ltd
- 62207-774 Ranitidine Hydrochloride 150 mg/1 · Tablet · Granules India Ltd
- 64980-636 Ranitidine Hydrochloride 150 mg/1 · Tablet · Rising Pharma Holdings, Inc.
- 64980-637 Ranitidine Hydrochloride 300 mg/1 · Tablet · Rising Pharma Holdings, Inc.
- 27241-109 Ranitidine Hydrochloride 150 mg/1 · Capsule · Ajanta Pharma USA Inc.
- 27241-110 Ranitidine Hydrochloride 300 mg/1 · Capsule · Ajanta Pharma USA Inc.
- 55111-404 Ranitidine Hydrochloride 150 mg/1 · Tablet, Coated · Dr. Reddy's Laboratories Limited
- 0121-0727 Ranitidine 15 mg/mL · Syrup · Pharmaceutical Associates, Inc.
- 0121-4727 Ranitidine 15 mg/mL · Syrup · Pharmaceutical Associates, Inc.